For integral membrane protein 2B, a recent serological study demonstrated that the antibodies produced by COVID-19 patients showed an unexpected immune response against integral membrane proteins, which can be used to detect SARS-CoV-2 variants or test vaccine effectiveness (59). This evidence concerns the gene ITM2B and COVID-19.